The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients: Mitoquinone and liver damage
Abstract
BACKGROUND: Increased oxidative stress and subsequent mitochondrial damage are important pathways for liver damage in chronic hepatitis C virus (HCV) infection; consequently, therapies that decrease mitochondrial oxidative damage may improve outcome. The mitochondria-targeted anti-oxidant mitoquinone combines a potent anti-oxidant with a lipophilic cation that causes it to accumulate several-hundred fold within mitochondria in vivo. AIMS: In this phase II study, we investigated the effect of oral mitoquinone on serum aminotransferases and HCV RNA levels in HCV-infected patients. METHODS: Thirty HCV patients who were either non-responders or unsuitable candidates for standard-of-care (pegylated interferon plus ribavirin) were randomized to receive mitoquinone (40 or 80 mg) or placebo once daily for 28 days, and serum aminotransferases and HCV RNA levels were measured. RESULTS: Both treatment groups showed significant decreases in absolute and percentage changes in serum alanine transaminase (ALT) from baseline to treatment day 28 (P<0.05). There was also a significant difference between incremental area under the curve for ALT between baseline and day 28 for the 40 mg treatment group against placebo (P<0.05). The differences in plasma ALT activity from baseline to day 28 in both mitoquinone groups compared with placebo did not reach significance (P>0.05). There was no change in HCV load on mitoquinone treatment. CONCLUSIONS: Administration of the mitochondria-targeted anti-oxidant mitoquinone significantly decreased plasma ALT and aspartate aminotransferase in patients with chronic HCV infection, and this suggests that mitoquinone may decrease necroinflammation in the liver in these patients. As mitochondrial oxidative damage contributes to many other chronic liver diseases, such as steatohepatitis, further studies using mitochondria-targeted anti-oxidants in HCV and other liver diseases are warranted.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Chronic hepatitis C patients treated with MitoQ for 28 days showed significant lowering of liver injury markers such as circulating alanine transaminase.
“In contrast, chronic hepatitis C patients treated with MitoQ for 28 days showed significant lowering of liver injury markers such as circulating alanine transaminase (333).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [333]
Cites
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207 · see citing works
Self-citationMcHutchison, J. G., Gordon, S. C., Schiff, E. R., Shiffman, M. L., Lee, W. M., Rustgi, V. K., Goodman, Z. D., Ling, M.-H., Cort, S., & Albrecht, J. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811193392101 · Cited by 3,457 · see citing works
The global burden of hepatitis C
Lavanchy, D. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01934.x · Cited by 1,353 · see citing works
Peginterferon Alfa-2a in Patients with Chronic Hepatitis C
Zeuzem, S., Feinman, S. V., Rasenack, J. W. F., Heathcote, E. J., Lai, M., Gane, E. J., O’Grady, J., Reichen, J., Moisés Diago, M., Lin, A., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012073432301 · Cited by 1,218 · see citing works
Self-citationTargeting Antioxidants to Mitochondria by Conjugation to Lipophilic Cations
Murphy, M. P., & Smith, R. A. J. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105110 · Cited by 1,173 · see citing works
Self-citationSelective Targeting of a Redox-active Ubiquinone to Mitochondria within Cells
Kelso, G. F., Porteous, C. M., Coulter, C. V., Hughes, G., Porteous, W. K., Ledgerwood, E. C., Smith, R. A. J., & Murphy, M. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009093200 · Cited by 1,091 · see citing works
Self-citationGlobal surveillance and control of hepatitis C
(1999) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.1999.6120139.x · Cited by 903 · see citing works
Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C
Liang, T. J., Rehermann, B., Seeff, L. B., & Hoofnagle, J. H. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-4-200002150-00008 · Cited by 868 · see citing works
Non‐alcoholic fatty liver disease
Angulo, P., & Lindor, K. D. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.17.s1.10.x · Cited by 838 · see citing works
Delivery of bioactive molecules to mitochondria <i>in</i> <i>vivo</i>
Smith, R. A. J., Porteous, C. M., Gane, A. M., & Murphy, M. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931245100 · Cited by 725 · see citing works
Self-citationTargeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury
Adlam, V. J., Harrison, J. C., Porteous, C. M., James, A. M., Smith, R. A. J., Murphy, M. P., & Sammut, I. A. (2005) · The FASEB Journal · doi:10.1096/fj.05-3718com · Cited by 618 · see citing works
Self-citationRoss, M. F., Kelso, G. F., Blaikie, F. H., James, A. M., Cochemé, H. M., Filipovska, A., Ros, T. D., Hurd, T. R., Smith, R. A. J., & Murphy, M. P. (2005) · Biochemistry (Moscow) · doi:10.1007/s10541-005-0104-5 · Cited by 495 · see citing works
Self-citationKorenaga, M., Wang, T., Li, Y., Showalter, L., Chan, T., Sun, J., & Weinman, S. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506412200 · Cited by 426 · see citing works
Mitochondria in Steatohepatitis
Pessayre, D., Berson, A., Fromenty, B., & Mansouri, A. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12929 · Cited by 390 · see citing works
Lavanchy, D. (1999) · PubMed · Cited by 374 · see citing works
Natural history of hepatitis C
Alberti, A., Chemello, L., & Benvegnù, L. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80369-9 · Cited by 366 · see citing works
Jauslin, M. L., Meier, T., Smith, R. A. J., & Murphy, P. M. (2003) · The FASEB Journal · doi:10.1096/fj.03-0240fje · Cited by 358 · see citing works
Self-citationLowes, D. A., Thottakam, B. M. V., Webster, N. R., Murphy, M. P., & Galley, H. F. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.09.003 · Cited by 261 · see citing works
Self-citationHepatitis C virus infection in the United States
Alter, M. J. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80381-x · Cited by 237 · see citing works
Management of chronic viral hepatitis before and after renal transplantation
Gane, E. J., & Pilmore, H. (2002) · Transplantation · doi:10.1097/00007890-200208270-00001 · Cited by 177 · see citing works
Self-citationNew Therapies for Hepatitis C Virus Infection
Soriano, V., Peters, M. G., & Zeuzem, S. (2009) · Clinical Infectious Diseases · doi:10.1086/595848 · Cited by 168 · see citing works
Deng, L., Adachi, T., Kitayama, K., Bungyoku, Y., Kitazawa, S., Ishido, S., Shoji, I., & Hotta, H. (2008) · Journal of Virology · doi:10.1128/jvi.00395-08 · Cited by 167 · see citing works
Liver diseases and metabolic syndrome
Watanabe, S., Yaginuma, R., Ikejima, K., & Miyazaki, A. (2008) · Journal of Gastroenterology · doi:10.1007/s00535-008-2193-6 · Cited by 157 · see citing works
Hepatitis B and hepatitis C in 2009
Marcellin, P. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01947.x · Cited by 141 · see citing works
Otani, K., Korenaga, M., Beard, M. R., Li, K., Qian, T., Showalter, L., Singh, A. K., Wang, T., & Weinman, S. A. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.10.045 · Cited by 134 · see citing works
Diamond, D. L., Jacobs, J. M., Paeper, B., Proll, S. C., Gritsenko, M. A., Carithers, R. L., Larson, A. M., Yeh, M. M., Camp, D. G., Smith, R. D., et al. (2007) · Hepatology · doi:10.1002/hep.21751 · Cited by 114 · see citing works
Self-citationComplex I Dysfunction and Tolerance to Nitroglycerin
Esplugues, J. V., Rocha, M., Nuñez, C., Boscá, I., Ibiza, S., Herance, J. R., Ortega, Á., Serrador, J. M., D’Ocón, P., & Víctor, V. M. (2006) · Circulation Research · doi:10.1161/01.res.0000250430.62775.99 · Cited by 103 · see citing works
Neužil, J., Widén, C., Gellert, N., Swettenham, E., Zobalová, R., Dong, L., Wang, X., Lidebjer, C., Dalen, H., Headrick, J. P., et al. (2007) · Redox Report · doi:10.1179/135100007x200227 · Cited by 91 · see citing works
Mitochondrial Dysfunction in Hepatitis C
Korenaga, M., Okuda, M., Otani, K., Wang, T., Li, Y., & Weinman, S. A. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000155517.02468.46 · Cited by 73 · see citing works
Nonalcoholic Fatty Liver Disease
Angulo, P. G. (2008) · CRC Press eBooks · doi:10.1201/b14432-44 · Cited by 67 · see citing works
Treatment of recurrent hepatitis C
Gane, E. J. (2002) · Liver Transplantation · doi:10.1053/jlts.2002.35860 · Cited by 54 · see citing works
Self-citationOptimal therapy in genotype 1 patients
Farnik, H., Mihm, U., & Zeuzem, S. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01969.x · Cited by 25 · see citing works
Li, Y., Zhang, H., Fawcett, J. P., & Tucker, I. G. (2007) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.3048 · Cited by 24 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
Zorov, D. B., Juhaszova, M., & Sollott, S. J. (2014) · Physiological Reviews · doi:10.1152/physrev.00026.2013 · Cited by 5,383 · see citing works
Zielonka, J., Joseph, J., Sikora, A., Hardy, M., Ouari, O., Vasquez-Vivar, J., Cheng, G., Lopez, M., & Kalyanaraman, B. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00042 · Cited by 1,683 · see citing works
Lood, C., Blanco, L. P., Purmalek, M. M., Carmona-Rivera, C., De Ravin, S. S., Smith, C. K., Malech, H. L., Ledbetter, J. A., Elkon, K. B., & Kaplan, M. J. (2016) · Nature Medicine · doi:10.1038/nm.4027 · Cited by 1,570 · see citing works
Mechanisms of hepatic fibrogenesis
Lee, U. E., & Friedman, S. L. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.02.005 · Cited by 923 · see citing works
Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances
Xu, X., Pang, Y., & Fan, X. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02253-4 · Cited by 939 · see citing works
Mitochondria as a therapeutic target for common pathologies
Murphy, M. P., & Hartley, R. C. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.174 · Cited by 832 · see citing works
Self-citationCell Death and Cell Death Responses in Liver Disease: Mechanisms and Clinical Relevance
Luedde, T., Kaplowitz, N., & Schwabe, R. F. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.07.018 · Cited by 760 · see citing works
Mitochondria and Mitochondrial ROS in Cancer: Novel Targets for Anticancer Therapy
Yang, Y., Karakhanova, S., Hartwig, W., D’Haese, J. G., Philippov, P. P., Werner, J., & Bazhin, A. V. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25349 · Cited by 671 · see citing works
Mitochondria in health, disease, and aging
Harrington, J. S., Ryter, S. W., Plataki, M. E., Price, D. R., & Choi, A. M. K. (2023) · Physiological Reviews · doi:10.1152/physrev.00058.2021 · Cited by 622 · see citing works
Xiao, L., Xu, X., Zhang, F., Wang, M., Xu, Y., Tang, D., Wang, J., Qin, Y., Liu, Y., Tang, C., et al. (2016) · Redox Biology · doi:10.1016/j.redox.2016.12.022 · Cited by 568 · see citing works
Animal and human studies with the mitochondria‐targeted antioxidant MitoQ
Smith, R. A. J., & Murphy, M. P. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05627.x · Cited by 553 · see citing works
Self-citationSources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation
Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541 · see citing works
Oxidative stress, anti‐oxidant therapies and chronic kidney disease
Small, D. M., Coombes, J. S., Bennett, N. J., Johnson, D. W., & Gobe, G. C. (2012) · Nephrology · doi:10.1111/j.1440-1797.2012.01572.x · Cited by 524 · see citing works
Mitochondria and Endothelial Function
Kluge, M. A., Fetterman, J. L., & Vita, J. A. (2013) · Circulation Research · doi:10.1161/circresaha.111.300233 · Cited by 508 · see citing works
Karam, B. S., Alejandro, C.-M., Koh, W.-J., Akar, J. G., & Akar, F. G. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0604-9 · Cited by 502 · see citing works
Smith, R. A. J., Hartley, R. C., Cochemé, H. M., & Murphy, M. P. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.03.010 · Cited by 501 · see citing works
Self-citationMitochondrial oxidative stress in aging and healthspan
Dai, D., Chiao, Y. A., Marcinek, D. J., Szeto, H. H., & Rabinovitch, P. S. (2014) · Longevity & Healthspan · doi:10.1186/2046-2395-3-6 · Cited by 481 · see citing works
Mitochondria‐targeted antioxidants
Oyewole, A. O., & Birch‐Machin, M. A. (2015) · The FASEB Journal · doi:10.1096/fj.15-275404 · Cited by 467 · see citing works
Rossman, M. J., Santos-Parker, J. R., Steward, C. A. C., Bispham, N. Z., Cuevas, L. M., Rosenberg, H. L., Woodward, K. A., Chonchol, M., Gioscia-Ryan, R. A., Murphy, M. P., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10787 · Cited by 456 · see citing works
Self-citationRole of Mitochondrial Calcium and the Permeability Transition Pore in Regulating Cell Death
Bauer, T. M., & Murphy, E. (2020) · Circulation Research · doi:10.1161/circresaha.119.316306 · Cited by 441 · see citing works
Mitochondria-Targeted Small Molecule Therapeutics and Probes
Smith, R. A. J., Hartley, R. C., & Murphy, M. P. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.3969 · Cited by 399 · see citing works
Self-citationCellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update
Elpek, G. Ö. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i23.7260 · Cited by 384 · see citing works
Jin, H., Kanthasamy, A., Ghosh, A., Anantharam, V., Kalyanaraman, B., & Kanthasamy, A. G. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.09.007 · Cited by 362 · see citing works
Mitochondria as a Cellular Hub in Infection and Inflammation
Andrieux, P., Chevillard, C., Cunha-Neto, E., & Nunes, J. P. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111338 · Cited by 346 · see citing works
Fisicaro, P., Barili, V., Montanini, B., Acerbi, G., Ferracin, M., Guerrieri, F., Salerno, D., Boni, C., Massari, M., Cavallo, M. C., et al. (2017) · Nature Medicine · doi:10.1038/nm.4275 · Cited by 344 · see citing works
Mitochondria in acute myocardial infarction and cardioprotection
Ramachandra, C. J. A., Hernández‐Reséndiz, S., Crespo-Avilan, G. E., Lin, Y., & Hausenloy, D. J. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102884 · Cited by 345 · see citing works
Cardiac Aging: From Molecular Mechanisms to Significance in Human Health and Disease
Dai, D.-F., Chen, T., Johnson, S. C., Szeto, H., & Rabinovitch, P. S. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4179 · Cited by 334 · see citing works
Mitochondria as a Therapeutic Target in Heart Failure
Bayeva, M., Gheorghiade, M., & Ardehali, H. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.08.1021 · Cited by 336 · see citing works
Battogtokh, G., Choi, Y. S., Kang, D. S., Park, S. J., Shim, M. S., Huh, K. M., Cho, Y., Lee, J. Y., Lee, H. S., & Kang, H. C. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.05.006 · Cited by 311 · see citing works
Mitochondrial Dysfunction in Heart Failure With Preserved Ejection Fraction
Kumar, A. A., Kelly, D. P., & Chirinos, J. A. (2019) · Circulation · doi:10.1161/circulationaha.118.036259 · Cited by 297 · see citing works
Mitochondrial Quality Control as a Therapeutic Target
Suliman, H. B., & Piantadosi, C. A. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.011502 · Cited by 265 · see citing works
Gioscia‐Ryan, R. A., LaRocca, T. J., Sindler, A. L., Zigler, M. C., Murphy, M. P., & Seals, D. R. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2013.268680 · Cited by 263 · see citing works
Self-citationCharlton, N. C., Mastyugin, M., Török, B., & Török, M. (2023) · Molecules · doi:10.3390/molecules28031057 · Cited by 278 · see citing works
Targeting Oxidative Stress for the Treatment of Liver Fibrosis
Luangmonkong, T., Suriguga, S., Mutsaers, H. A. M., Groothuis, G. M. M., Olinga, P., & Boersema, M. (2018) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2018_10 · Cited by 248 · see citing works
Antioxidants as therapeutic agents for liver disease
Singal, A. K., Jampana, S. C., & Weinman, S. A. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02604.x · Cited by 234 · see citing works
Macdonald, R., Barnes, K., Hastings, C., & Mortiboys, H. (2018) · Biochemical Society Transactions · doi:10.1042/bst20170501 · Cited by 216 · see citing works
McElwain, C. J., Tuboly, E., McCarthy, F. P., & McCarthy, C. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00655 · Cited by 224 · see citing works
Kang, L., Liu, S., Li, J., Tian, Y., Xue, Y., & Liu, X. (2020) · Cell Proliferation · doi:10.1111/cpr.12779 · Cited by 212 · see citing works
Zinovkin, R. A., & Zamyatnin, A. A. (2019) · Current Molecular Pharmacology · doi:10.2174/1874467212666181127151059 · Cited by 209 · see citing works
Cunha‐Oliveira, T., Montezinho, L., Mendes, C., Firuzi, O., Saso, L., Oliveira, P. J., & Silva, F. S. G. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5021694 · Cited by 214 · see citing works
Dashdorj, A., Jyothi, K. R., Lim, S., Jo, A., Nguyen, M. N., Ha, J., Yoon, K., Kim, H. J., Park, J., Murphy, M. P., et al. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-178 · Cited by 206 · see citing works
Self-citationMitochondria-Targeted Antioxidants: A Step towards Disease Treatment
Jiang, Q., Yin, J., Chen, J., Ma, X., Wu, M., Liu, G., Kang, Y., Tan, B., & Yin, Y. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8837893 · Cited by 210 · see citing works
Prevention of diabetic nephropathy in Ins2+/−AkitaJ mice by the mitochondria-targeted therapy MitoQ
Chacko, B. K., Reily, C., Srivastava, A., Johnson, M. S., Ye, Y., Ulasova, E., Agarwal, A., Zinn, K. R., Murphy, M. P., Kalyanaraman, B., et al. (2010) · Biochemical Journal · doi:10.1042/bj20100308 · Cited by 204 · see citing works
Self-citationDare, A. J., Bolton, E. A., Pettigrew, G. J., Bradley, J. A., Saeb-Parsy, K., & Murphy, M. P. (2015) · Redox Biology · doi:10.1016/j.redox.2015.04.008 · Cited by 202 · see citing works
Self-citationZheng, Y., Wang, S., Wu, J., & Wang, Y. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04367-1 · Cited by 192 · see citing works
Organelle-level precision with next-generation targeting technologies
Saminathan, A., Zajac, M. A., Anees, P., & Krishnan, Y. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00396-8 · Cited by 189 · see citing works
NOD-like receptor signaling in inflammation-associated cancers: From functions to targeted therapies
Liu, P., Lu, Z., Liu, L., Li, R., Liang, Z., Shen, M., Han, X., Ren, D., Ji, M., Yuan, S., et al. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.152925 · Cited by 173 · see citing works
Cardiopulmonary Bypass and Oxidative Stress
Zakkar, M., Guida, G. A., Suleiman, M. S., & Angelini, G. D. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/189863 · Cited by 171 · see citing works
Anxiety and Brain Mitochondria: A Bidirectional Crosstalk
Filiou, M. D., & Sandi, C. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.07.002 · Cited by 164 · see citing works
Mitochondria and Inflammatory Bowel Diseases: Toward a Stratified Therapeutic Intervention
Ho, G., & Theiss, A. L. (2021) · Annual Review of Physiology · doi:10.1146/annurev-physiol-060821-083306 · Cited by 162 · see citing works
Millard, M., Gallagher, J. D., Olenyuk, B. Z., & Neamati, N. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4012438 · Cited by 160 · see citing works
Understanding and preventing mitochondrial oxidative damage
Murphy, M. P. (2016) · Biochemical Society Transactions · doi:10.1042/bst20160108 · Cited by 160 · see citing works
Self-citationOxidative stress and hepatitis C virus
Paracha, U. Z., Fatima, K., Alqahtani, M. H., Chaudhary, A., Abuzenadah, A. M., Damanhouri, G. A., & Qadri, I. (2013) · Virology Journal · doi:10.1186/1743-422x-10-251 · Cited by 156 · see citing works
Granata, S., Votrico, V., Spadaccino, F., Catalano, V., Netti, G. S., Ranieri, E., Stallone, G., & Zaza, G. (2022) · Antioxidants · doi:10.3390/antiox11040769 · Cited by 155 · see citing works
Solesio, M. E., Prime, T. A., Logan, A., Murphy, M. P., Jiménez, M. D. M. A., Jordán, J., & Galindo, M. F. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.07.009 · Cited by 150 · see citing works
Self-citationMolecular Vehicles for Mitochondrial Chemical Biology and Drug Delivery
Jean, S. R., Tulumello, D. V., Wisnovsky, S., Lei, E. K., Pereira, M. P., & Kelley, S. O. (2014) · ACS Chemical Biology · doi:10.1021/cb400821p · Cited by 144 · see citing works
Goh, K. Y., He, L., Song, J., Jinno, M., Rogers, A. J., Sethu, P., Halade, G. V., Rajasekaran, N. S., Liu, X., Prabhu, S. D., et al. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101100 · Cited by 142 · see citing works
Reduction in mitochondrial iron alleviates cardiac damage during injury
Chang, H., Wu, R., Shang, M., Sato, T., Chen, C., Shapiro, J. S., Liu, T., Thakur, A., Sawicki, K. T., Prasad, S. V. N., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505748 · Cited by 137 · see citing works
Gruber, J., Fong, S., Chen, C.-B., Yoong, S. L., Pastorin, G., Schaffer, S., Cheah, I. K.-M., & Halliwell, B. B. (2012) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.09.005 · Cited by 138 · see citing works
Bioavailability of Coenzyme Q10: An Overview of the Absorption Process and Subsequent Metabolism
Mantle, D., & Dybring, A. (2020) · Antioxidants · doi:10.3390/antiox9050386 · Cited by 134 · see citing works
Mukhopadhyay, P., Horváth, B., Zsengellér, Z. K., Bátkai, S., Cao, Z., Kechrid, M., Holovac, E., Erdélyi, K., Tanchian, G., Liaudet, L., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.036 · Cited by 132 · see citing works
Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?
Ciaula, A. D., Passarella, S., Shanmugam, H., Noviello, M., Bonfrate, L., Wang, D. Q. ‐., & Portincasa, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105375 · Cited by 133 · see citing works
Wood, E., Hall, K., & Tate, W. P. (2020) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2020.11.002 · Cited by 129 · see citing works
Mitochondria‐Targeted Antioxidants: Future Perspectives in Kidney Ischemia Reperfusion Injury
Kezić, A., Spasojević, I., Ležaić, V., & Bajčetić, M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/2950503 · Cited by 129 · see citing works
Al-Zubaidi, U., Adhikari, D., Çınar, Ö., Zhang, Q.-H., Yuen, W. S., Murphy, M. P., Rombauts, L. J. F., Robker, R. L., & Carroll, J. (2020) · Human Reproduction · doi:10.1093/humrep/deaa300 · Cited by 124 · see citing works
Self-citationBrand, M. D. (2020) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2020.1828258 · Cited by 123 · see citing works
Song, B.-J., Akbar, M., Abdelmegeed, M. A., Byun, K., Lee, B., Yoon, S. K., & Hardwick, J. P. (2014) · Redox Biology · doi:10.1016/j.redox.2014.10.004 · Cited by 123 · see citing works
“Thus, protein nitration serves as one of the critical causal factors in APAP-induced acute liver damage usually observed at later time points.”
BackgroundMitochondria-targeted ubiquinone (MitoQ) decreases ethanol-dependent micro and macro hepatosteatosis
Chacko, B. K., Srivastava, A., Johnson, M. S., Benavides, G. A., Chang, M. J., Ye, Y., Jhala, N., Murphy, M. P., Kalyanaraman, B., & Darley-Usmar, V. M. (2011) · Hepatology · doi:10.1002/hep.24377 · Cited by 122 · see citing works
Self-citationMitochondria: a new therapeutic target in chronic kidney disease
Granata, S., Gassa, A. D., Tomei, P., Lupo, A., & Zaza, G. (2015) · Nutrition & Metabolism · doi:10.1186/s12986-015-0044-z · Cited by 122 · see citing works
Porteous, C. M., Logan, A., Evans, C., Ledgerwood, E. C., Menon, D. K., Aigbirhio, F., Smith, R. A. J., & Murphy, M. P. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2010.06.001 · Cited by 121 · see citing works
Self-citationYoong, S. L., Wong, B. S., Zhou, Q., Chin, C. F., Li, J., Venkatesan, T., Ho, H. K., Yu, V. C. K., Ang, W. H., & Pastorin, G. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.036 · Cited by 121 · see citing works
Evolving Concepts of Oxidative Stress and Reactive Oxygen Species in Cardiovascular Disease
Chen, K., & Keaney, J. F. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0266-8 · Cited by 119 · see citing works
Mitochondrial calcium and reactive oxygen species in cardiovascular disease
Murphy, E., & Liu, J. C. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac134 · Cited by 120 · see citing works
Dare, A. J., Logan, A., Prime, T. A., Rogatti, S., Goddard, M., Bolton, E. M., Bradley, J. A., Pettigrew, G. J., Murphy, M. P., & Saeb-Parsy, K. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.05.007 · Cited by 119 · see citing works
Self-citationApplication Prospects of Triphenylphosphine-Based Mitochondria-Targeted Cancer Therapy
Cheng, X., Feng, D., Lv, J., Cui, X., Wang, Y., Wang, Q., & Zhang, L. (2023) · Cancers · doi:10.3390/cancers15030666 · Cited by 115 · see citing works
Role of Metabolic Reprogramming in Pulmonary Innate Immunity and Its Impact on Lung Diseases
Michaeloudes, C., Bhavsar, P. K., Mumby, S. E., Xu, B., Hui, C., Chung, K. F., & Adcock, I. M. (2019) · Journal of Innate Immunity · doi:10.1159/000504344 · Cited by 114 · see citing works
Mitochondria-Targeted Antioxidants for Treatment of Hearing Loss: A Systematic Review
Fujimoto, C., & Yamasoba, T. (2019) · Antioxidants · doi:10.3390/antiox8040109 · Cited by 108 · see citing works
Potential therapy strategy: targeting mitochondrial dysfunction in sepsis
Zhang, H., Feng, Y., & Yao, Y.-M. (2018) · Military Medical Research · doi:10.1186/s40779-018-0187-0 · Cited by 110 · see citing works
Infection with the dengue RNA virus activates TLR9 signaling in human dendritic cells
Lai, J., Wang, M., Huang, C., Wu, C., Hung, L., Yang, C., Ke, P., Luo, S., Liu, S., & Ho, L. (2018) · EMBO Reports · doi:10.15252/embr.201846182 · Cited by 108 · see citing works
Role of Drp1, a Key Mitochondrial Fission Protein, in Neuropathic Pain
Ferrari, L. F., Chum, A., Bogen, O., Reichling, D. B., & Levine, J. D. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2223-11.2011 · Cited by 107 · see citing works
Lim, S., Rashid, M. A., Jang, M., Kim, Y., Won, H., Lee, J., Woo, J., Kim, Y. S., Murphy, M. P., Ali, L., et al. (2011) · Cellular Physiology and Biochemistry · doi:10.1159/000335802 · Cited by 106 · see citing works
Self-citationNew antiviral therapies for chronic hepatitis C
Kanda, T., Imazeki, F., & Yokosuka, O. (2010) · Hepatology International · doi:10.1007/s12072-010-9193-3 · Cited by 105 · see citing works
Dong, L., Jameson, V. J. A., Tilly, D., Procházka, L., Rohlena, J., Vališ, K., Truksa, J., Zobalová, R., Mahdavian, E., Kľučková, K., et al. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.02.032 · Cited by 105 · see citing works
Self-citationMitochondrion‐Permeable Antioxidants to Treat ROS‐Burst‐Mediated Acute Diseases
Zhang, Z., Xu, X., Liu, T., & Yuan, S. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/6859523 · Cited by 106 · see citing works
Zang, Q. S., Sadek, H. A., Maass, D. L., Martinez, B., Ma, L., Kilgore, J. A., Williams, N. S., Frantz, D. E., Wigginton, J. G., Nwariaku, F. E., et al. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00203.2011 · Cited by 103 · see citing works
Warne, J., Pryce, G., Hill, J. M., Shi, X., Lennerås, F., Puentes, F., Kip, M., Hilditch, L., Walker, P., Simone, M. I., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.700385 · Cited by 99 · see citing works
Mitochondrial Dysfunction in Cardiovascular Diseases: Potential Targets for Treatment
Yang, J., Guo, Q., Feng, X., Liu, Y., & Zhou, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.841523 · Cited by 102 · see citing works
Yamada, Y., Nakamura, K., Abe, J., Hyodo, M., Haga, S., Ozaki, M., & Harashima, H. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.06.037 · Cited by 99 · see citing works
Mitochondrial energetics and calcium coupling in the heart
Kohlhaas, M., Nickel, A. G., & Maack, C. (2017) · The Journal of Physiology · doi:10.1113/jp273609 · Cited by 98 · see citing works
Rapamycin‐mediated mouse lifespan extension: Late‐life dosage regimes with sex‐specific effects
Strong, R., Miller, R. A., Bogue, M. A., Fernández, E., Javors, M. A., Libert, S., Martinez, P. A., Murphy, M. P., Musi, N., Nelson, J. F., et al. (2020) · Aging Cell · doi:10.1111/acel.13269 · Cited by 99 · see citing works
Self-citationNuzzo, A. M., Camm, E. J., Sferruzzi-Perri, A. N., Ashmore, T. J., Yung, H. W., Cindrová‐Davies, T., Spiroski, A., Sutherland, M. R., Logan, A., Austin‐Williams, S., et al. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.07.027 · Cited by 94 · see citing works
Self-citationTriphenylphosphonium (TPP)‐Based Antioxidants: A New Perspective on Antioxidant Design
Wang, J., Li, J. Q., Xiao, Y., Fu, B., & Qin, Z. (2020) · ChemMedChem · doi:10.1002/cmdc.201900695 · Cited by 99 · see citing works
Maini, M. K., & Pallett, L. J. (2018) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(18)30007-4 · Cited by 94 · see citing works
Impact of the mitochondria-targeted antioxidant MitoQ on hypoxia-induced pulmonary hypertension
Pak, O., Scheibe, S., Esfandiary, A., Gierhardt, M., Sydykov, A. S., Logan, A., Fysikopoulos, A., Veit, F., Hecker, M., Kroschel, F., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.01024-2017 · Cited by 95 · see citing works
Self-citationHuang, M., Myers, C. R., Wang, Y., & You, M. (2020) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-20-0425 · Cited by 97 · see citing works
Fortner, K. A., Blanco, L. P., Buskiewicz, I. A., Huang, N., Gibson, P. C., Cook, D. L., Pedersen, H. L., Yuen, P. S. T., Murphy, M. P., Perl, A., et al. (2020) · Lupus Science & Medicine · doi:10.1136/lupus-2020-000387 · Cited by 94 · see citing works
Self-citationDrug Development for the Therapy of Mitochondrial Diseases
Weissig, V. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.09.002 · Cited by 92 · see citing works
Co‐enzyme Q10 and idebenone use in Friedreich's ataxia
Parkinson, M. H., Schulz, J. B., & Giunti, P. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12322 · Cited by 92 · see citing works
Coenzyme Q10 Analogues: Benefits and Challenges for Therapeutics
Suarez-Rivero, J. M., Pastor‐Maldonado, C. J., Povea-Cabello, S., Álvarez-Córdoba, M., Villalón-García, I., Munuera-Cabeza, M., Suárez-Carrillo, A., Talaverón-Rey, M., & Sánchez-Alcázar, J. A. (2021) · Antioxidants · doi:10.3390/antiox10020236 · Cited by 94 · see citing works
Interventions for age-related diseases: Shifting the paradigm
Figueira, I., Fernandes, A. M. A., Mladenović, A., Lopez-Contreras, A. J., Henriques, C. M., Selman, C., Ferreiro, E. B., Gonos, E. S., Trejo, J. L., Misra, J., et al. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.09.009 · Cited by 87 · see citing works
- Authors
- Gane, E. J., Weilert, F., Orr, D. W., Keogh, G. F., Gibson, M., Lockhart, M. M., Frampton, C. M., Taylor, K. M., Smith, R. A. J., & Murphy, M. P.
- Affiliations
- Auckland City Hospital (NZ)
- Waikato Hospital (NZ)
- University of Otago (NZ)
- MRC Mitochondrial Biology Unit (GB)
- Corresponding author
- Gane, Edward J.
- Venue
- Liver International
- Publisher
- Wiley
- Published
- 2010-05-18
- Volume
- 30
- Issue
- 7
- Pages
- 1019-1026
- ISSN
- 0106-9543 (ISSN-L)
- 1478-3223
- 1478-3231
- OpenAlex
- W1623473717
- Cited by
- 379
- References
- 33
- Citations by year
- 2026: 18 · 2025: 29 · 2024: 15 · 2023: 26 · 2022: 29 · 2021: 27 · 2020: 33 · 2019: 24 · 2018: 28 · 2017: 21 · 2016: 24 · 2015: 21 · 2014: 23 · 2013: 18 · 2012: 23
- FWCI
- 12.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Liver International (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- mitoquinone, chronic hepatitis C, mitochondria-targeted antioxidants, oxidative stress, mitochondrial damage, liver injury, alanine aminotransferase, aspartate aminotransferase, HCV RNA viral load, necroinflammation
- MeSH terms
- Administration, Oral, Adult, Alanine Transaminase, Antioxidants, Antiviral Agents, Aspartate Aminotransferases, Double-Blind Method, Female, Genotype, Humans, Interferons, Liver, Male, Middle Aged, Mitochondria, Liver, Organophosphorus Compounds, Ribavirin, RNA, Viral, Time Factors, Ubiquinone, Biomarkers, Hepacivirus, Treatment Outcome, Viral Load, Hepatitis C, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
